Saturday, July 11, 2026

Drug profile · INN

toremifene citrate

toremifene citrate (TOREMIFENE CITRATE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — toremifene citrate
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

toremifene citrate (TOREMIFENE CITRATE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN toremifene citrate
Brand TOREMIFENE CITRATE
Mechanism Estrogen receptor modulator
Target Estrogen receptor
Route ORAL
Formulation TABLET

Mechanism of action

Estrogen receptor modulator

Primary target: Estrogen receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. estradiol Estrogen receptor alpha agonist
  2. estradiol valerate Estrogen receptor alpha agonist
  3. estrogens, conjugated synthetic a Estrogen receptor agonist
  4. estropipate Estrogen receptor alpha agonist
  5. ethinyl estradiol Estrogen receptor alpha agonist
  6. fulvestrant Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is toremifene citrate?

toremifene citrate (TOREMIFENE CITRATE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for toremifene citrate?

TOREMIFENE CITRATE is a marketed brand name for toremifene citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of toremifene citrate?

toremifene citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.